DOI: 10.1055/s-00000009

American Journal of Perinatology

References

Quick RD, Merkel K, Murphey DK, Fernandez M, Hauger SB.
Impact of adopting 2014 guidance for palivizumab prophylaxis for children previously considered at high risk for severe respiratory syncytial virus disease.
Int J Respir Pulm Med 2017 4(072)

Download Bibliographical Data

Search in: